Nan-horng Lin, Ph.d.

Biography

  Dr. Nan-Horng Lin received his Ph.D. degree from Indiana University, USA. With more than 30 years of experience in pharmaceutical industry, Dr. Lin specializes in synthetic organic chemistry, medicinal chemistry, new target identification, hit to lead optimization and general research management in pharmaceutical and CRO companies. Prior to joining CHO Pharma, Dr. Lin served as the Director of Institute of Pharmaceutics of Development Center for Biotechnology (DCB), Senior Vice President of Crown Bioscience Inc., Chief Scientific Officer of Medicilon Inc. and Senior Group Leader and Research Fellow of Abbott Laboratories. During his tenure with Abbott, Dr. Lin led several R&D projects and had successfully identified four clinical candidates which had entered Phase II and Phase III trials. Dr. Lin experiences in identifying clinical candidates as well as building and leading highly productive research team in drug discovery and CRO organizations. Now, Dr. Lin brings his experience in R&D technology and his business acumen to CHO Pharma Inc. and continues to focus on producing innovative and niche products.

Research Interest

Pharma